drugset / Trial / NCT06048627

Anti-gingivitis Mouthrinse

NCT06048627

Phase 3 Completed 90 enrolled Colgate Palmolive
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to prove whether a fluoride/zinc lactate containing mouthrinse is able to reduce dental plaque and gingival inflammation in patients who have gingivitis when applied twice daily during brushing at home over a period of 12 weeks.

Timeline

Start
2024-03-06
Primary completion
2024-10-01
Completion
2024-10-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Zinc Lactate Unknown 250 ppm Oral
Subject sodium fluoride Unknown 250 ppm Oral

Indications